Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression

Futoshi Okada, Hiroshi Tazawa, Tokushige Kobayashi, Masanobu Kobayashi, Masuo Hosokawa

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The cells of a weakly tumorigenic and non-metastatic murine fibrosarcoma (QR-32) are converted into highly malignant tumors (acquiring metastatic potential) once they have grown in vivo after being co-implanted with gelatin sponge which induces inflammation. In the present study, we examined whether nitric oxide (NO) is involved in the inflammation-based tumor progression by administrating a specific inhibitor to inducible nitric oxide synthase, aminoguanidine (AG). First, we co-implanted 1 × 105 QR-32 cells with gelatin sponge (10 × 5 × 3 mm piece) into a subcutaneous space in C57BL6 mice. Administration of AG in drinking water (1%) had started 2 days before the tumor implantation and continued until the termination of the experiment. The incidence of tumor formation and the tumor growth did not differ between AG-treated group and -untreated group. On day 28, we excised the arising tumors to establish culture cell lines for evaluation of their acquisition of metastatic phenotype in other normal mice. Metastasis incidence and the number of metastatic colonies were significantly reduced in the tumor cell lines obtained from AG-treated mice compared to those from non-treated mice (p <0.05). Immunohistochemical analysis demonstrated that inducible nitric oxide synthase and nitrotyrosine in the inflamed lesion were reduced in the AG-administered mice. However, intensity of 8-hydroxy-2-deoxyguanosine was not different between the groups. These results showed that nitric oxide and its reactive nitrogen oxide species cooperatively play a pivotal role in the progression of benign tumor cells in inflamed lesions.

Original languageEnglish
Pages (from-to)122-129
Number of pages8
JournalNitric Oxide - Biology and Chemistry
Volume14
Issue number2 SPEC. ISS.
DOIs
Publication statusPublished - Mar 2006
Externally publishedYes

Fingerprint

Nitrogen Oxides
Tumors
Inflammation
Neoplasms
Nitric Oxide
Porifera
Nitric Oxide Synthase Type II
Gelatin
Reactive Nitrogen Species
Cells
Fibrosarcoma
Incidence
Tumor Cell Line
Drinking Water
Cell culture
pimagedine
Neoplasm Metastasis
Phenotype
Cell Line
Growth

Keywords

  • Fibrosarcoma cells
  • Inflammation
  • Metastasis
  • Reactive nitrogen oxides
  • Tumor progression

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression. / Okada, Futoshi; Tazawa, Hiroshi; Kobayashi, Tokushige; Kobayashi, Masanobu; Hosokawa, Masuo.

In: Nitric Oxide - Biology and Chemistry, Vol. 14, No. 2 SPEC. ISS., 03.2006, p. 122-129.

Research output: Contribution to journalArticle

@article{138d0827d1da4b589b20c1c149a43e0e,
title = "Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression",
abstract = "The cells of a weakly tumorigenic and non-metastatic murine fibrosarcoma (QR-32) are converted into highly malignant tumors (acquiring metastatic potential) once they have grown in vivo after being co-implanted with gelatin sponge which induces inflammation. In the present study, we examined whether nitric oxide (NO) is involved in the inflammation-based tumor progression by administrating a specific inhibitor to inducible nitric oxide synthase, aminoguanidine (AG). First, we co-implanted 1 × 105 QR-32 cells with gelatin sponge (10 × 5 × 3 mm piece) into a subcutaneous space in C57BL6 mice. Administration of AG in drinking water (1{\%}) had started 2 days before the tumor implantation and continued until the termination of the experiment. The incidence of tumor formation and the tumor growth did not differ between AG-treated group and -untreated group. On day 28, we excised the arising tumors to establish culture cell lines for evaluation of their acquisition of metastatic phenotype in other normal mice. Metastasis incidence and the number of metastatic colonies were significantly reduced in the tumor cell lines obtained from AG-treated mice compared to those from non-treated mice (p <0.05). Immunohistochemical analysis demonstrated that inducible nitric oxide synthase and nitrotyrosine in the inflamed lesion were reduced in the AG-administered mice. However, intensity of 8-hydroxy-2-deoxyguanosine was not different between the groups. These results showed that nitric oxide and its reactive nitrogen oxide species cooperatively play a pivotal role in the progression of benign tumor cells in inflamed lesions.",
keywords = "Fibrosarcoma cells, Inflammation, Metastasis, Reactive nitrogen oxides, Tumor progression",
author = "Futoshi Okada and Hiroshi Tazawa and Tokushige Kobayashi and Masanobu Kobayashi and Masuo Hosokawa",
year = "2006",
month = "3",
doi = "10.1016/j.niox.2005.06.009",
language = "English",
volume = "14",
pages = "122--129",
journal = "Nitric Oxide - Biology and Chemistry",
issn = "1089-8603",
publisher = "Academic Press Inc.",
number = "2 SPEC. ISS.",

}

TY - JOUR

T1 - Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression

AU - Okada, Futoshi

AU - Tazawa, Hiroshi

AU - Kobayashi, Tokushige

AU - Kobayashi, Masanobu

AU - Hosokawa, Masuo

PY - 2006/3

Y1 - 2006/3

N2 - The cells of a weakly tumorigenic and non-metastatic murine fibrosarcoma (QR-32) are converted into highly malignant tumors (acquiring metastatic potential) once they have grown in vivo after being co-implanted with gelatin sponge which induces inflammation. In the present study, we examined whether nitric oxide (NO) is involved in the inflammation-based tumor progression by administrating a specific inhibitor to inducible nitric oxide synthase, aminoguanidine (AG). First, we co-implanted 1 × 105 QR-32 cells with gelatin sponge (10 × 5 × 3 mm piece) into a subcutaneous space in C57BL6 mice. Administration of AG in drinking water (1%) had started 2 days before the tumor implantation and continued until the termination of the experiment. The incidence of tumor formation and the tumor growth did not differ between AG-treated group and -untreated group. On day 28, we excised the arising tumors to establish culture cell lines for evaluation of their acquisition of metastatic phenotype in other normal mice. Metastasis incidence and the number of metastatic colonies were significantly reduced in the tumor cell lines obtained from AG-treated mice compared to those from non-treated mice (p <0.05). Immunohistochemical analysis demonstrated that inducible nitric oxide synthase and nitrotyrosine in the inflamed lesion were reduced in the AG-administered mice. However, intensity of 8-hydroxy-2-deoxyguanosine was not different between the groups. These results showed that nitric oxide and its reactive nitrogen oxide species cooperatively play a pivotal role in the progression of benign tumor cells in inflamed lesions.

AB - The cells of a weakly tumorigenic and non-metastatic murine fibrosarcoma (QR-32) are converted into highly malignant tumors (acquiring metastatic potential) once they have grown in vivo after being co-implanted with gelatin sponge which induces inflammation. In the present study, we examined whether nitric oxide (NO) is involved in the inflammation-based tumor progression by administrating a specific inhibitor to inducible nitric oxide synthase, aminoguanidine (AG). First, we co-implanted 1 × 105 QR-32 cells with gelatin sponge (10 × 5 × 3 mm piece) into a subcutaneous space in C57BL6 mice. Administration of AG in drinking water (1%) had started 2 days before the tumor implantation and continued until the termination of the experiment. The incidence of tumor formation and the tumor growth did not differ between AG-treated group and -untreated group. On day 28, we excised the arising tumors to establish culture cell lines for evaluation of their acquisition of metastatic phenotype in other normal mice. Metastasis incidence and the number of metastatic colonies were significantly reduced in the tumor cell lines obtained from AG-treated mice compared to those from non-treated mice (p <0.05). Immunohistochemical analysis demonstrated that inducible nitric oxide synthase and nitrotyrosine in the inflamed lesion were reduced in the AG-administered mice. However, intensity of 8-hydroxy-2-deoxyguanosine was not different between the groups. These results showed that nitric oxide and its reactive nitrogen oxide species cooperatively play a pivotal role in the progression of benign tumor cells in inflamed lesions.

KW - Fibrosarcoma cells

KW - Inflammation

KW - Metastasis

KW - Reactive nitrogen oxides

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=31544469761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544469761&partnerID=8YFLogxK

U2 - 10.1016/j.niox.2005.06.009

DO - 10.1016/j.niox.2005.06.009

M3 - Article

C2 - 16125421

AN - SCOPUS:31544469761

VL - 14

SP - 122

EP - 129

JO - Nitric Oxide - Biology and Chemistry

JF - Nitric Oxide - Biology and Chemistry

SN - 1089-8603

IS - 2 SPEC. ISS.

ER -